Vanberra Signal

Biomodex

Curated by Signal

3D printed surgical simulators for medical education and patient-specific preoperative planning

Overview

Biomodex develops 3D printed surgical simulators for medical education and patient-specific preoperative planning. The company uses techniques three-dimensional modeling and advanced 3D printers to produce exact copies of organs that can be used to train staff medical and under preoperative simulations. From biomedical imaging data of organs from MRI or scanners, the company has developed a process that helps to automate the creation of virtual 3D models of these organs which can then be printed using a 3D printer. Products are offered for bone drilling, soft tissue suturing, and medical device implantation and sizing, including pathology specifications, medical imaging segmentation, biomechanical modeling, organ 3D printing, simulation environment, and surgical simulation procedures. The company received an investment of $ 3.6M led by Innovation Capital to expand in the US.

Key facts

Founded
2014
Headquarters
Paris, France

Business model

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • App for emergency house call and telemedicine

    Health TechnologyParis, France
  • Provider of a device for manual lymphatic drainage at home

    Health TechnologyLille, France
  • Provider of AI-based software for data management

    Health TechnologyRhone Alpes, France

About Biomodex

What does Biomodex do?

Biomodex develops 3D printed surgical simulators for medical education and patient-specific preoperative planning.

Where is Biomodex headquartered?

Biomodex is headquartered in Paris, France.

When was Biomodex founded?

Biomodex was founded in 2014.

Which sector is Biomodex in?

Biomodex operates in Health Technology.

Who are Biomodex's competitors?

Companies similar to Biomodex include Urgence Docteurs, Naoo, and PREVIA.